As You Know, Controlling Tourette’s Is Not This Easy.
We invite boys and girls aged 6 to 17 who have a diagnosis of Tourette syndrome to see if they may qualify for the T-Force Platinum Research Study. The primary purpose of this research study is to evaluate the safety and effectiveness of an investigational medication, that is not an antipsychotic medication, in pediatric patients with Tourette syndrome.
During the study, you may undergo the following:
Participants in the T-Force Platinum Research Study will need to:
Attend a Screening Visit to determine eligibility
Participate in the clinical research study for up to 44 weeks, including up to 17 visits at a local study site
Receive up to a total of 36 weeks of daily study drug dosing
Attend a Follow-Up Visit after completing applicable study visits
Those who qualify will receive either the investigational medication or placebo (inactive substance), study-related medical exams, and study-related laboratory tests at no cost. Compensation for time and travel may also be available.
Interested to enroll in a study?
See if you qualify today